{"title": "Nach Corona-Impfkampagne: Impfpolitik muss ge\u00e4ndert werden", "author": "Resch Media", "url": "https://individuelle-impfentscheidung.de/impfungen/covid-19.html", "hostname": "individuelle-impfentscheidung.de", "description": "Nach den Folgen der Corona-Impfkampagne fordern die \u00c4FI: evidenzbasierte Impfempfehlungen und eine Neuausrichtung von RKI, STIKO und PEI.", "sitename": "individuelle-impfentscheidung.de", "date": "2023-03-30", "id": null, "license": null, "body": null, "comments": "", "commentsbody": null, "raw_text": null, "text": "Abbasi, J. (2023). What to Know About EG.5, the Latest SARS-CoV-2 \u201cVariant of Interest\u201d. JAMA, 330(10), 900\u2013901.\n[https://doi.org/10.1001/jama.2023.16498](https://doi.org/10.1001/jama.2023.16498)\nAgarwal, G., Hajra, A., Chakraborty, S., Patel, N., Biswas, S., Adler, M. K., & Lavie, C. J. (2022). Predictors and mortality risk of venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis of observational studies. Therapeutic Advances in Cardiovascular Disease, 16, 17539447221105012.\n[https://doi.org/10.1177/17539447221105013](https://doi.org/10.1177/17539447221105013)\nAkbarialiabad, H., Taghrir, M. H., Abdollahi, A., Ghahramani, N., Kumar, M., Paydar, S., Razani, B., Mwangi, J., Asadi-Pooya, A. A., Malekmakan, L., & Bastani, B. (2021). Long COVID, a comprehensive systematic scoping review. Infection, 49(6), 1163\u20131186.\n[https://doi.org/10.1007/s15010-021-01666-x](https://doi.org/10.1007/s15010-021-01666-x)\nAlimohamadi, Y., Tola, H. H., Abbasi-Ghahramanloo, A., Janani, M., & Sepandi, M. (2021). Case fatality rate of COVID-19: A systematic review and meta-analysis. Journal of Preventive Medicine and Hygiene, 62(2), E311\u2013E320.\n[https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1627](https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1627)\nAlmamlouk, R., Kashour, T., Obeidat, S., Bois, M. C., Maleszewski, J. J., Omrani, O. A., Tleyjeh, R., Berbari, E., Chakhachiro, Z., Zein-Sabatto, B., Gerberi, D., Tleyjeh, I. M., Cardiac Autopsy in COVID-19 Study Group, Paniz Mondolfi, A. E., Finn, A. V., Duarte-Neto, A. N., Rapkiewicz, A. V., Frustaci, A., Keresztesi, A.-A., \u2026 Grimes, Z. (2022). COVID-19-Associated cardiac pathology at the postmortem evaluation: A collaborative systematic review. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 28(8), 1066\u20131075.\n[https://doi.org/10.1016/j.cmi.2022.03.021](https://doi.org/10.1016/j.cmi.2022.03.021)\nAntonelli, M., Pujol, J. C., Spector, T. D., Ourselin, S., & Steves, C. J. (2022). Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2. Lancet (London, England), 399(10343), 2263\u20132264.\n[https://doi.org/10.1016/S0140-6736(22)00941-2](https://doi.org/10.1016/S0140-6736(22)00941-2)\nArbel, R., Hammerman, A., & Netzer, D. (2023). Bivalent Boosters against Severe Omicron Infection. New England Journal of Medicine, 388(18), 1726\u20131727.\n[https://doi.org/10.1056/NEJMc2303753](https://doi.org/10.1056/NEJMc2303753)\nBarrett, R., Youssef, M., Shah, I., Ioana, J., Lawati, A. A., Bukhari, A., Hegarty, S., Cormican, L. J., Judge, E., Burke, C. M., Cody, C., Feely, J., Hutchinson, K., Tormey, W., Neill, E. O., Shea, A. O., Connolly, M., McCartney, D. M. A., & Faul, J. L. (2022). Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults. Nutrients, 14(16), 3252.\n[https://doi.org/10.3390/nu14163252](https://doi.org/10.3390/nu14163252)\nBazargan, M., Elahi, R., & Esmaeilzadeh, A. (2022). OMICRON: Virology, immunopathogenesis, and laboratory diagnosis. The Journal of Gene Medicine, 24(7), e3435.\n[https://doi.org/10.1002/jgm.3435](https://doi.org/10.1002/jgm.3435)\nBenn, C. S., Schaltz-Buchholzer, F., Nielsen, S., Netea, M. G., & Aaby, P. (2023). Randomized clinical trials of COVID-19 vaccines: Do adenovirus-vector vaccines have beneficial non-specific effects? IScience, 26(5).\n[https://doi.org/10.1016/j.isci.2023.106733](https://doi.org/10.1016/j.isci.2023.106733)\nBobrovitz, N., Ware, H., Ma, X., Li, Z., Hosseini, R., Cao, C., Selemon, A., Whelan, M., Premji, Z., Issa, H., Cheng, B., Abu Raddad, L. J., Buckeridge, D. L., Van Kerkhove, M. D., Piechotta, V., Higdon, M. M., Wilder-Smith, A., Bergeri, I., Feikin, D. R., \u2026 Subissi, L. (2023). Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: A systematic review and meta-regression. The Lancet. Infectious Diseases, S1473-3099(22)00801-5.\n[https://doi.org/10.1016/S1473-3099(22)00801-5](https://doi.org/10.1016/S1473-3099(22)00801-5)\nBodderas, E. (2022, Dezember 15). \u201eUS-Gesundheitsbeh\u00f6rde lie\u00df sich von acht Laborm\u00e4usen \u00fcberzeugen\u201c. DIE WELT.\n[https://www.welt.de/politik/deutschland/plus241005455/Corona-Impfung-US-Gesundheitsbehoerde-liess-sich-von-acht-Labormaeusen-ueberzeugen.html](https://www.welt.de/politik/deutschland/plus241005455/Corona-Impfung-US-Gesundheitsbehoerde-liess-sich-von-acht-Labormaeusen-ueberzeugen.html)\nBodderas, E., L\u00fcbberding, F., R\u00f6hn, T., & Stibi, B. (2022, Juli 6). Corona-Impfung: 2,5 Millionen Patienten meldeten Nebenwirkungen in Deutschland\u2014WELT. DIE WELT.\n[https://www.welt.de/politik/deutschland/plus239736199/Corona-Impfung-2-5-Millionen-Patienten-meldeten-Nebenwirkungen-in-Deutschland.html](https://www.welt.de/politik/deutschland/plus239736199/Corona-Impfung-2-5-Millionen-Patienten-meldeten-Nebenwirkungen-in-Deutschland.html)\nBourdas, D. I., Bakirtzoglou, P., Travlos, A. K., Andrianopoulos, V., & Zacharakis, E. (2023). Exploring the Impact of COVID-19 on Physical Activity One Month after Infection and Its Potential Determinants: Re-Infections, Pre-Illness Vaccination Profiles/Types, and Beyond. Vaccines, 11(9), Article 9.\n[https://doi.org/10.3390/vaccines11091431](https://doi.org/10.3390/vaccines11091431)\nBowe, B., Xie, Y., & Al-Aly, Z. (2022). Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nature Medicine, 28(11), 2398\u20132405.\n[https://doi.org/10.1038/s41591-022-02051-3](https://doi.org/10.1038/s41591-022-02051-3)\nBrown, M., Gerrard, J., McKinlay, L., Marquess, J., Sparrow, T., & Andrews, R. (2023). Ongoing symptoms and functional impairment 12 weeks after testing positive to SARS-CoV-2 or influenza in Australia: An observational cohort study (S. 2023.04.16.23288205). medRxiv.\n[https://doi.org/10.1101/2023.04.16.23288205](https://doi.org/10.1101/2023.04.16.23288205)\nBundesministerium f\u00fcr Gesundheit. (2023, M\u00e4rz 4). Impfdashboard. impfdashboard.de.\n[https://impfdashboard.de/](https://impfdashboard.de/)\nBundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung. (2022, November 10). Infektion mit dem Coronavirus: Symptome und Krankheitsverlauf. infektionsschutz.de.\n[https://www.infektionsschutz.de/coronavirus/basisinformationen/symptome-und-krankheitsverlauf/](https://www.infektionsschutz.de/coronavirus/basisinformationen/symptome-und-krankheitsverlauf/)\nCallaway, E. (2022). New Omicron-specific vaccines offer similar protection to existing boosters. Nature, 609(7926), 232\u2013233.\n[https://doi.org/10.1038/d41586-022-02806-5](https://doi.org/10.1038/d41586-022-02806-5)\nChebotareva, N., Berns, S., Androsova, T., & Moiseev, S. (2021). Acute kidney damage in COVID-19 patients. Clinical Nephrology, 95(5), 227\u2013239.\n[https://doi.org/10.5414/CN110357](https://doi.org/10.5414/CN110357)\nChen, C., Haupert, S. R., Zimmermann, L., Shi, X., Fritsche, L. G., & Mukherjee, B. (2022). Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. The Journal of Infectious Diseases, 226(9), 1593\u20131607.\n[https://doi.org/10.1093/infdis/jiac136](https://doi.org/10.1093/infdis/jiac136)\nCheung, C., & Cheung, B. M. Y. (2021). Vitamin D and COVID-19: Causal factor or bystander? Postgraduate Medical Journal, 97(1149), 413\u2013414.\n[https://doi.org/10.1136/postgradmedj-2020-139388](https://doi.org/10.1136/postgradmedj-2020-139388)\nCorona Mediziner Allianz. (2023, M\u00e4rz). Leitf\u00e4den. CORMEA.\n[https://www.cormea.de](https://www.cormea.de)\nCho, J. Y., Kim, K. H., Lee, N., Cho, S. H., Kim, S. Y., Kim, E. K., Park, J.-H., Choi, E.-Y., Choi, J.-O., Park, H., Kim, H. Y., Yoon, H. J., Ahn, Y., Jeong, M. H., & Cho, J. G. (2023). COVID-19 vaccination-related myocarditis: A Korean nationwide study. European Heart Journal, ehad339.\n[https://doi.org/10.1093/eurheartj/ehad339](https://doi.org/10.1093/eurheartj/ehad339)\nCross, R. (2021, M\u00e4rz 6). Without these lipid shells, there would be no mRNA vaccines for COVID-19. American Chemical Society.\n[https://cen.acs.org/pharmaceuticals/drug-delivery/Without-lipid-shells-mRNA-vaccines/99/i8](https://cen.acs.org/pharmaceuticals/drug-delivery/Without-lipid-shells-mRNA-vaccines/99/i8)\nDel \u00c1guila-Mej\u00eda, J., Wallmann, R., Calvo-Montes, J., Rodr\u00edguez-Lozano, J., Valle-Madrazo, T., & Aginagalde-Llorente, A. (2022). Secondary Attack Rate, Transmission and Incubation Periods, and Serial Interval of SARS-CoV-2 Omicron Variant, Spain. Emerging Infectious Diseases, 28(6), 1224\u20131228.\n[https://doi.org/10.3201/eid2806.220158](https://doi.org/10.3201/eid2806.220158)\nDeutsche Gesellschaft f\u00fcr Allgemeinmedizin und Familienmedizin e.V., Deutsche Gesellschaft f\u00fcr Internistische Intensivmedizin und Notfallmedizin e.V., Deutsche Gesellschaft f\u00fcr Infektiologie e.V., Deutsche Gesellschaft f\u00fcr Pneumologie und Beatmungsmedizin e.V., Deutsche Gesellschaft f\u00fcr Innere Medizin e.V., Deutsche Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie e.V., Deutsche Gesellschaft f\u00fcr Rheumatologie e.V., Deutsche Gesellschaft f\u00fcr Kinder- und Jugendmedizin e.V., & Deutsche AIDS-Gesellschaft e.V. (2023, Februar 1). S2e-Leitlinie SARS-CoV-2 / Covid-19 Informationen und Praxishilfen f\u00fcr niedergelassene Haus\u00e4rztinnen und Haus\u00e4rzte\u2014Living Guideline. AWMF Leitlinien Register.\n[https://register.awmf.org/de/leitlinien/detail/053-054](https://register.awmf.org/de/leitlinien/detail/053-054)\nDeutsche Gesellschaft f\u00fcr P\u00e4diatrische Infektiologie e. V. (2023). Ad hoc Atemwegsinfektions-Erfassung, w\u00f6chentliches Update. DGPI.\n[https://dgpi.de/awi-erfassung-update/](https://dgpi.de/awi-erfassung-update/)\nDeutsche Interdisziplin\u00e4re Vereinigung f\u00fcr Intensiv- und Notfallmedizin (DIVI) e.V. & Robert Koch-Institut. (2023, M\u00e4rz 24). Zeitreihen. intensivregister.de.\n[https://www.intensivregister.de/#/aktuelle-lage/zeitreihen](https://www.intensivregister.de/#/aktuelle-lage/zeitreihen)\nDeutsches \u00c4rzteblatt. (2023, Februar 2). Immune Imprinting: Kann Impfen S\u00fcnde sein? aerzteblatt.de.\n[https://www.aerzteblatt.de/nachrichten/140205/Immune-Imprinting-Kann-Impfen-Suende-sein](https://www.aerzteblatt.de/nachrichten/140205/Immune-Imprinting-Kann-Impfen-Suende-sein)\nDingermann, T. (2023, August 18). Angepasste Covid-19-Impfstoffe wirksam gegen EG.5. Pharmazeutische Zeitung online.\n[https://www.pharmazeutische-zeitung.de/angepasste-covid-19-impfstoffe-wirksam-gegen-eg5-141829/](https://www.pharmazeutische-zeitung.de/angepasste-covid-19-impfstoffe-wirksam-gegen-eg5-141829/)\nDuijster, J. W., Schoep, M. E., Nieboer, T. E., Jajou, R., Kant, A., & Van Hunsel, F. (2023). Menstrual abnormalities after COVID-19 vaccination in the Netherlands: A description of spontaneous and longitudinal patient-reported data. British Journal of Clinical Pharmacology.\n[https://doi.org/10.1111/bcp.15799](https://doi.org/10.1111/bcp.15799)\nErbguth, F., F\u00f6rstl, H., & Kleinschnitz, C. (2023, M\u00e4rz 31). Long COVID und die Psycho-Ecke: Wiedergeburt eines reduktionistischen Krankheitsverst\u00e4ndnisses. Deutsches \u00c4rzteblatt.\n[https://www.aerzteblatt.de/archiv/230476/Long-COVID-und-die-Psycho-Ecke-Wiedergeburt-eines-reduktionistischen-Krankheitsverstaendnisses](https://www.aerzteblatt.de/archiv/230476/Long-COVID-und-die-Psycho-Ecke-Wiedergeburt-eines-reduktionistischen-Krankheitsverstaendnisses)\nEurop\u00e4ische Kommission. (2022, September 2). EU-Kommission l\u00e4sst angepasste Impfstoffe von BioNTech und Moderna zu. EU-Kommission.\n[https://germany.representation.ec.europa.eu/news/eu-kommission-lasst-angepasste-impfstoffe-von-biontech-und-moderna-zu-2022-09-02_de](https://germany.representation.ec.europa.eu/news/eu-kommission-lasst-angepasste-impfstoffe-von-biontech-und-moderna-zu-2022-09-02_de)\nEuser, S., Aronson, S., Manders, I., van Lelyveld, S., Herpers, B., Sinnige, J., Kalpoe, J., van Gemeren, C., Snijders, D., Jansen, R., Schuurmans Stekhoven, S., van Houten, M., Lede, I., Cohen Stuart, J., Slijkerman Megelink, F., Kapteijns, E., den Boer, J., Sanders, E., Wagemakers, A., & Souverein, D. (2022). SARS-CoV-2 viral-load distribution reveals that viral loads increase with age: A retrospective cross-sectional cohort study. International Journal of Epidemiology, 50(6), 1795\u20131803.\n[https://doi.org/10.1093/ije/dyab145](https://doi.org/10.1093/ije/dyab145)\nFeldt, T., Karagiannidis, C., Mager, S., Mikolajewska, A., Uhrig, A., Witzke, O., Wolf, T., Beutel, G., & Lachmann, G. (2020). Welche Rolle spielt ein m\u00f6gliches Hyperinflammationssyndrom bei einer schweren COVID-19-Infektion und k\u00f6nnen hieraus Konsequenzen f\u00fcr die Therapie gezogen werden? Robert Koch-Institut.\n[https://doi.org/10.25646/7037](https://doi.org/10.25646/7037)\nFeltham, E., Forastiere, L., Alexander, M., & Christakis, N. A. (2023). Mass gatherings for political expression had no discernible association with the local course of the COVID-19 pandemic in the USA in 2020 and 2021. Nature Human Behaviour, 1\u201321.\n[https://doi.org/10.1038/s41562-023-01654-1](https://doi.org/10.1038/s41562-023-01654-1)\nFOCUS online. (2022, Oktober 3). Impfstoff-RNA in Muttermilch: Experten sagen, wie gef\u00e4hrlich das ist. focus.de.\n[https://www.focus.de/gesundheit/coronaimpfung-impfstoff-rna-in-muttermilch-nachgewiesen-was-das-nun-fuer-muetter-bedeutet_id_154659625.html](https://www.focus.de/gesundheit/coronaimpfung-impfstoff-rna-in-muttermilch-nachgewiesen-was-das-nun-fuer-muetter-bedeutet_id_154659625.html)\nFOCUS online. (2023, Februar 1). 253 anerkannte Impfsch\u00e4den \u2013 die 6 wichtigsten Fragen.\n[https://www.focus.de/gesundheit/coronavirus/seltene-schwere-nebenwirkungen-253-faelle-in-deutschland-die-6-wichtigsten-fragen-zu-impfschaeden_id_184560185.html](https://www.focus.de/gesundheit/coronavirus/seltene-schwere-nebenwirkungen-253-faelle-in-deutschland-die-6-wichtigsten-fragen-zu-impfschaeden_id_184560185.html)\nFox, T., Hunt, B. J., Ariens, R. A., Towers, G. J., Lever, R., Garner, P., & Kuehn, R. (2023). Plasmapheresis to remove amyloid fibrin(ogen) particles for treating the post\u2010COVID\u201019 condition. Cochrane Database of Systematic Reviews, 7.\n[https://doi.org/10.1002/14651858.CD015775](https://doi.org/10.1002/14651858.CD015775)\nFrutos, A. M., Kuan, G., Lopez, R., Ojeda, S., Shotwell, A., Sanchez, N., Saborio, S., Plazaola, M., Barilla, C., Kenah, E., Balmaseda, A., & Gordon, A. (2022). Infection-induced immunity is associated with protection against SARS-CoV-2 infection, but not decreased infectivity during household transmission. MedRxiv: The Preprint Server for Health Sciences, 2022.10.10.22280915.\n[https://doi.org/10.1101/2022.10.10.22280915](https://doi.org/10.1101/2022.10.10.22280915)\nFu, C., Lin, N., Zhu, J., & Ye, Q. (2023). Association between Overweight/Obesity and the Safety and Efficacy of COVID-19 Vaccination: A Systematic Review. Vaccines, 11(5), Article 5.\n[https://doi.org/10.3390/vaccines11050996](https://doi.org/10.3390/vaccines11050996)\nGabbai-Armelin, P. R., de Oliveira, A. B., Ferrisse, T. M., Sales, L. S., Barbosa, E. R. O., Miranda, M. L., Salom\u00e3o, K. B., & Brighenti, F. L. (2021). COVID-19 (SARS-CoV-2) infection and thrombotic conditions: A systematic review and meta-analysis. European Journal of Clinical Investigation, 51(6), e13559.\n[https://doi.org/10.1111/eci.13559](https://doi.org/10.1111/eci.13559)\nGao, J., Feng, L., Li, Y., Lowe, S., Guo, Z., Bentley, R., Xie, C., Wu, B., Xie, P., Xia, W., Ma, S., Liu, H., Guo, X., Uy, J. P. N., Zhou, Q., Wazir, H., & Sun, C. (2023). A Systematic Review and Meta-analysis of the Association Between SARS-CoV-2 Vaccination and Myocarditis or Pericarditis. American Journal of Preventive Medicine, 64(2), 275\u2013284.\n[https://doi.org/10.1016/j.amepre.2022.09.002](https://doi.org/10.1016/j.amepre.2022.09.002)\nGie\u00dfelmann, K., & Martin, M. (2022, Mai 13). Post-Vac-Syndrom: Seltene Folgen nach Impfung. Deutsches \u00c4rzteblatt.\n[https://www.aerzteblatt.de/archiv/225071/Post-Vac-Syndrom-Seltene-Folgen-nach-Impfung](https://www.aerzteblatt.de/archiv/225071/Post-Vac-Syndrom-Seltene-Folgen-nach-Impfung)\nGuemes-Villahoz, N., Burgos-Blasco, B., Echevarria-Torres, P. L., Vidal-Villegas, B., Rodriguez de la Pe\u00f1a, A., Diaz-Valle, D., Fern\u00e1ndez-Vigo, J. I., S\u00e1nchez-Ram\u00f3n, S., & Garcia-Feijoo, J. (2023). Detection of anti-SARS-CoV-2 antibodies in tears: Ocular surface immunity to COVID-19. Archivos De La Sociedad Espanola De Oftalmologia, S2173-5794(23)00083-X.\n[https://doi.org/10.1016/j.oftale.2023.05.009](https://doi.org/10.1016/j.oftale.2023.05.009)\nGustine, J. N., & Jones, D. (2021). Immunopathology of Hyperinflammation in COVID-19. The American Journal of Pathology, 191(1), 4\u201317.\n[https://doi.org/10.1016/j.ajpath.2020.08.009](https://doi.org/10.1016/j.ajpath.2020.08.009)\nHan, Q., Zheng, B., Daines, L., & Sheikh, A. (2022). Long-Term Sequelae of COVID-19: A Systematic Review and Meta-Analysis of One-Year Follow-Up Studies on Post-COVID Symptoms. Pathogens (Basel, Switzerland), 11(2), 269.\n[https://doi.org/10.3390/pathogens11020269](https://doi.org/10.3390/pathogens11020269)\nHanna, N., Heffes-Doon, A., Lin, X., Manzano De Mejia, C., Botros, B., Gurzenda, E., & Nayak, A. (2022). Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk. JAMA Pediatrics, 176(12), 1268\u20131270.\n[https://doi.org/10.1001/jamapediatrics.2022.3581](https://doi.org/10.1001/jamapediatrics.2022.3581)\nHanna, N., Mejia, C. M. D., Heffes-Doon, A., Lin, X., Botros, B., Gurzenda, E., Clauss-Pascarelli, C., & Nayak, A. (2023). Biodistribution of mRNA COVID-19 vaccines in human breast milk. eBioMedicine, 96.\n[https://doi.org/10.1016/j.ebiom.2023.104800](https://doi.org/10.1016/j.ebiom.2023.104800)\nHasan, D., Shono, A., van Kalken, C. K., van der Spek, P. J., Krenning, E. P., & Kotani, T. (2022). A novel definition and treatment of hyperinflammation in COVID-19 based on purinergic signalling. Purinergic Signalling, 18(1), 13\u201359.\n[https://doi.org/10.1007/s11302-021-09814-6](https://doi.org/10.1007/s11302-021-09814-6)\nHazell, L., & Shakir, S. A. W. (2006). Under-reporting of adverse drug reactions: A systematic review. Drug Safety,29(5), 385\u2013396.\n[https://doi.org/10.2165/00002018-200629050-00003](https://doi.org/10.2165/00002018-200629050-00003)\nHealth Advisory & Recovery Team. (2022, August 14). Measuring the extent of the Myocarditis Iceberg? Safety lessons from smallpox vaccination. HART.\n[https://www.hartgroup.org/measuring-the-extent-of-the-myocarditis-iceberg/](https://www.hartgroup.org/measuring-the-extent-of-the-myocarditis-iceberg/)\nHirt, J., Janiaud, P., Gloy, V. L., Schandelmaier, S., Pereira, T. V., Contopoulos-Ioannidis, D., Goodman, S. N., Ioannidis, J., Munkholm, K., & Hemkens, L. G. (2022). Robustness of reported postacute health outcomes in children with SARS-CoV-2 infection: A systematic review. Archives of Disease in Childhood, archdischild-2022-324455.\n[https://doi.org/10.1136/archdischild-2022-324455](https://doi.org/10.1136/archdischild-2022-324455)\nH\u00f8eg, T. B., Duriseti, R., & Prasad, V. (2023). Potential \u201cHealthy Vaccinee Bias\u201d in a Study of BNT162b2 Vaccine against Covid-19. New England Journal of Medicine, 389(3), 284\u2013286.\n[https://doi.org/10.1056/NEJMc2306683](https://doi.org/10.1056/NEJMc2306683)\nHusby, A., Gulseth, H. L., Hovi, P., Hansen, J. V., Pihlstr\u00f6m, N., Gunnes, N., H\u00e4rk\u00e4nen, T., Dahl, J., Karlstad, \u00d8., Heli\u00f6, T., K\u00f8ber, L., Ljung, R., & Hviid, A. (2023). Clinical outcomes of myocarditis after SARS-CoV-2 mRNA vaccination in four Nordic countries: Population based cohort study. BMJ Medicine, 2(1), e000373.\n[https://doi.org/10.1136/bmjmed-2022-000373](https://doi.org/10.1136/bmjmed-2022-000373)\nInstitute for Health Metrics and Evaluation. (2021, M\u00e4rz 4). COVID-19 vaccine efficacy summary. IHME.\n[https://www.healthdata.org/covid/covid-19-vaccine-efficacy-summary](https://www.healthdata.org/covid/covid-19-vaccine-efficacy-summary)\nJones, S. E., Maisha, F. I., Strausz, S. J., Lammi, V., Cade, B. E., Tervi, A., Helaakoski, V., Broberg, M. E., FinnGen, Lane, J. M., Redline, S., Saxena, R., & Ollila, H. M. (2023). The public health impact of poor sleep on severe COVID-19, influenza and upper respiratory infections. EBioMedicine,\n[104630. https://doi.org/10.1016/j.ebiom.2023.104630](http://104630.)\nJones, T. C., Biele, G., M\u00fchlemann, B., Veith, T., Schneider, J., Beheim-Schwarzbach, J., Bleicker, T., Tesch, J., Schmidt, M. L., Sander, L. E., Kurth, F., Menzel, P., Schwarzer, R., Zuchowski, M., Hofmann, J., Krumbholz, A., Stein, A., Edelmann, A., Corman, V. M., & Drosten, C. (2021). Estimating infectiousness throughout SARS-CoV-2 infection course. Science, 373(6551), eabi5273.\n[https://doi.org/10.1126/science.abi5273](https://doi.org/10.1126/science.abi5273)\nJordan, T., Siuka, D., Rotovnik, N. K., & Pfeifer, M. (2022). COVID-19 and Vitamin D- a Systematic Review. Zdravstveno Varstvo, 61(2), 124\u2013132.\n[https://doi.org/10.2478/sjph-2022-0017](https://doi.org/10.2478/sjph-2022-0017)\nKarlstad, \u00d8., Hovi, P., Husby, A., H\u00e4rk\u00e4nen, T., Selmer, R. M., Pihlstr\u00f6m, N., Hansen, J. V., Nohynek, H., Gunnes, N., Sundstr\u00f6m, A., Wohlfahrt, J., Nieminen, T. A., Gr\u00fcnewald, M., Gulseth, H. L., Hviid, A., & Ljung, R. (2022). SARS-CoV-2 Vaccination and Myocarditis in a Nordic Cohort Study of 23 Million Residents. JAMA Cardiology, 7(6), 600\u2013612.\n[https://doi.org/10.1001/jamacardio.2022.0583](https://doi.org/10.1001/jamacardio.2022.0583)\nKaryakarte, R. P., Das, R., Rajmane, M. V., Dudhate, S., Agarasen, J., Pillai, P., Chandankhede, P. M., Labhshetwar, R. S., Gadiyal, Y., Kulkarni, P. P., Nizarudeen, S., Joshi, S., Karmodiya, K., & Potdar, V. (2023). Chasing SARS-CoV-2 XBB.1.16 Recombinant Lineage in India and the Clinical Profile of XBB.1.16 Cases in Maharashtra, India. Cureus, 15(6), e39816.\n[https://doi.org/10.7759/cureus.39816](https://doi.org/10.7759/cureus.39816)\nKhoury, D. S., Docken, S. S., Subbarao, K., Kent, S. J., Davenport, M. P., & Cromer, D. (2023). Predicting the efficacy of variant-modified COVID-19 vaccine boosters. Nature Medicine, 29(3), 574\u2013578.\n[https://doi.org/10.1038/s41591-023-02228-4](https://doi.org/10.1038/s41591-023-02228-4)\nKim, K., Cho, K., Song, J., Rahmati, M., Koyanagi, A., Lee, S. W., Yon, D. K., Il Shin, J., & Smith, L. (2023). The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis. Journal of Medical Virology, 95(2), e28522.\n[https://doi.org/10.1002/jmv.28522](https://doi.org/10.1002/jmv.28522)\nKlugar, M., Riad, A., Mekhemar, M., Conrad, J., Buchbender, M., Howaldt, H.-P., & Attia, S. (2021). Side Effects of mRNA-Based and Viral Vector-Based COVID-19 Vaccines among German Healthcare Workers. Biology, 10(8), 752.\n[https://doi.org/10.3390/biology10080752](https://doi.org/10.3390/biology10080752)\nKo, L., Malet, G., Chang, L. L., Nguyen, H., Mayes, R., Ko, L., Malet, G., Chang, L., Nguyen, H., & Mayes, R. (2023). COVID-19 Infection Rates in Vaccinated and Unvaccinated Inmates: A Retrospective Cohort Study. Cureus, 15(9).\n[https://doi.org/10.7759/cureus.44684](https://doi.org/10.7759/cureus.44684)\nKurhade, C., Zou, J., Xia, H., Liu, M., Chang, H. C., Ren, P., Xie, X., & Shi, P.-Y. (2023). Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster. Nature Medicine, 29(2), 344\u2013347.\n[https://doi.org/10.1038/s41591-022-02162-x](https://doi.org/10.1038/s41591-022-02162-x)\nLasrado, N., Collier, A.-R. Y., Miller, J., Hachmann, N. P., Liu, J., Sciacca, M., Wu, C., Anand, T., Bondzie, E. A., Fisher, J. L., Mazurek, C. R., Patio, R. C., Powers, O., Rodrigues, S. L., Rowe, M., Surve, N., Ty, D. M., Korber, B., & Barouch, D. H. (2023). Waning Immunity Against XBB.1.5 Following Bivalent mRNA Boosters. BioRxiv: The Preprint Server for Biology, 2023.01.22.525079.\n[https://doi.org/10.1101/2023.01.22.525079](https://doi.org/10.1101/2023.01.22.525079)\nLewnard, J. A., Hong, V., Kim, J. S., Shaw, S. F., Lewin, B., Takhar, H., & Tartof, S. Y. (2023). Association of SARS-CoV-2 BA.4/BA.5 Omicron lineages with immune escape and clinical outcome. Nature Communications, 14(1), 1407.\n[https://doi.org/10.1038/s41467-023-37051-5](https://doi.org/10.1038/s41467-023-37051-5)\nLi, H.-J., Yang, Q.-C., Yao, Y.-Y., Huang, C.-Y., Yin, F.-Q., Xian-Yu, C.-Y., Zhang, C., & Chen, S.-J. (2023). COVID-19 vaccination effectiveness and safety in vulnerable populations: A meta-analysis of 33 observational studies. Frontiers in Pharmacology, 14, 1144824.\n[https://doi.org/10.3389/fphar.2023.1144824](https://doi.org/10.3389/fphar.2023.1144824)\nLippi, G., Sanchis-Gomar, F., & Henry, B. M. (2023). COVID-19 and its long-term sequelae: What do we know in 2023? Polish Archives of Internal Medicine, 16402.\n[https://doi.org/10.20452/pamw.16402](https://doi.org/10.20452/pamw.16402)\nLopez-Leon, S., Wegman-Ostrosky, T., Perelman, C., Sepulveda, R., Rebolledo, P. A., Cuapio, A., & Villapol, S. (2021). More than 50 long-term effects of COVID-19: A systematic review and meta-analysis. Scientific Reports, 11(1), 16144.\n[https://doi.org/10.1038/s41598-021-95565-8](https://doi.org/10.1038/s41598-021-95565-8)\nLyngse, F. P., Mortensen, L. H., Denwood, M. J., Christiansen, L. E., M\u00f8ller, C. H., Skov, R. L., Spiess, K., Fomsgaard, A., Lassauni\u00e8re, R., Rasmussen, M., Stegger, M., Nielsen, C., Sieber, R. N., Cohen, A. S., M\u00f8ller, F. T., Overvad, M., M\u00f8lbak, K., Krause, T. G., & Kirkeby, C. T. (2022). Household transmission of the SARS-CoV-2 Omicron variant in Denmark. Nature Communications, 13(1), Article 1.\n[https://doi.org/10.1038/s41467-022-33328-3](https://doi.org/10.1038/s41467-022-33328-3)\nMa, Q., Liu, J., Liu, Q., Kang, L., Liu, R., Jing, W., Wu, Y., & Liu, M. (2021). Global Percentage of Asymptomatic SARS-CoV-2 Infections Among the Tested Population and Individuals With Confirmed COVID-19 Diagnosis: A Systematic Review and Meta-analysis. JAMA Network Open, 4(12), e2137257.\n[https://doi.org/10.1001/jamanetworkopen.2021.37257](https://doi.org/10.1001/jamanetworkopen.2021.37257)\nMahase, E. (2023). Covid-19: New \u201cPirola\u201d variant BA.2.86 continues to spread in UK and US. BMJ, 382, p2097.\n[https://doi.org/10.1136/bmj.p2097](https://doi.org/10.1136/bmj.p2097)\nMadewell, Z. J., Yang, Y., Longini, I. M., Halloran, M. E., & Dean, N. E. (2022). Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis. JAMA Network Open, 5(4), e229317.\n[https://doi.org/10.1001/jamanetworkopen.2022.9317](https://doi.org/10.1001/jamanetworkopen.2022.9317)\nMadhi, S. A., Ihekweazu, C., Rees, H., & Pollard, A. J. (2022). Decoupling of omicron variant infections and severe COVID-19. Lancet (London, England), 399(10329), 1047\u20131048.\n[https://doi.org/10.1016/S0140-6736(22)00109-X](https://doi.org/10.1016/S0140-6736(22)00109-X)\nMagnusson, K., Turkiewicz, A., Flottorp, S. A., & Englund, M. (2023). Prevalence of long COVID complaints in persons with and without COVID-19. Scientific Reports, 13(1), Article 1.\n[https://doi.org/10.1038/s41598-023-32636-y](https://doi.org/10.1038/s41598-023-32636-y)\nMalato, J., Ribeiro, R. M., Leite, P. P., Casaca, P., Fernandes, E., Antunes, C., Fonseca, V. R., Gomes, M. C., & Graca, L. (2022). Risk of BA.5 Infection among Persons Exposed to Previous SARS-CoV-2 Variants. The New England Journal of Medicine, 387(10), 953\u2013954.\n[https://doi.org/10.1056/NEJMc2209479](https://doi.org/10.1056/NEJMc2209479)\nMansanguan, S., Charunwatthana, P., Piyaphanee, W., Dechkhajorn, W., Poolcharoen, A., & Mansanguan, C. (2022). Cardiovascular Manifestation of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents. Tropical Medicine and Infectious Disease, 7(8), 196.\n[https://doi.org/10.3390/tropicalmed7080196](https://doi.org/10.3390/tropicalmed7080196)\nMansory, E. M., Abu-Farhaneh, M., Iansavitchene, A., & Lazo-Langner, A. (2022). Venous and Arterial Thrombosis in Ambulatory and Discharged COVID-19 Patients: A Systematic Review and Meta-analysis. TH Open: Companion Journal to Thrombosis and Haemostasis, 6(3), e276\u2013e282.\n[https://doi.org/10.1055/a-1913-4377](https://doi.org/10.1055/a-1913-4377)\nMatysik, J. (2023, Februar 24). Biontech-Impfstoff: Kein Polydispersit\u00e4tstest vom Paul-Ehrlich-Institut. Berliner Zeitung.\n[https://www.berliner-zeitung.de/wirtschaft-verantwortung/corona-pandemie-gastbeitrag-biontech-impfstoff-kein-polydispersitaetstest-vom-paul-ehrlich-institut-li.321577](https://www.berliner-zeitung.de/wirtschaft-verantwortung/corona-pandemie-gastbeitrag-biontech-impfstoff-kein-polydispersitaetstest-vom-paul-ehrlich-institut-li.321577)\nMDR. (2021, September 30). Stimmt nicht: Es gibt eine unfreiweillige Corona-Impfung via Muttermilch. mdr.de.\n[https://www.mdr.de/wissen/faktencheck/faktencheck-impfung-muttermilch-100.html](https://www.mdr.de/wissen/faktencheck/faktencheck-impfung-muttermilch-100.html)\nMedi\u0107, S., Anastassopoulou, C., Lozanov-Crvenkovi\u0107, Z., Vukovi\u0107, V., Dragni\u0107, N., Petrovi\u0107, V., Risti\u0107, M., Pustahija, T., Gojkovi\u0107, Z., Tsakris, A., & Ioannidis, J. P. A. (2022). Risk and severity of SARS-CoV-2 reinfections during 2020\u20132022 in Vojvodina, Serbia: A population-level observational study. The Lancet Regional Health \u2013 Europe, 20.\n[https://doi.org/10.1016/j.lanepe.2022.100453](https://doi.org/10.1016/j.lanepe.2022.100453)\nMehrabi Nejad, M.-M., Moosaie, F., Dehghanbanadaki, H., Haji Ghadery, A., Shabani, M., Tabary, M., Aryannejad, A., SeyedAlinaghi, S., & Rezaei, N. (2022). Immunogenicity of COVID-19 mRNA vaccines in immunocompromised patients: A systematic review and meta-analysis. European Journal of Medical Research, 27(1), 23.\n[https://doi.org/10.1186/s40001-022-00648-5](https://doi.org/10.1186/s40001-022-00648-5)\nMenegale, F., Manica, M., Zardini, A., et al. (2023). Evaluation of Waning of SARS-CoV-2 Vaccine\u2013Induced Immunity: A Systematic Review and Meta-analysis. JAMA Netw Open, 6(5), e2310650.\n[https://10.1001/jamanetworkopen.2023.10650](https://10.0.3.233/jamanetworkopen.2023.10650)\nMichelen, M., Manoharan, L., Elkheir, N., Cheng, V., Dagens, A., Hastie, C., O\u2019Hara, M., Suett, J., Dahmash, D., Bugaeva, P., Rigby, I., Munblit, D., Harriss, E., Burls, A., Foote, C., Scott, J., Carson, G., Olliaro, P., Sigfrid, L., & Stavropoulou, C. (2021). Characterising long COVID: A living systematic review. BMJ Global Health, 6(9), e005427.\n[https://doi.org/10.1136/bmjgh-2021-005427](https://doi.org/10.1136/bmjgh-2021-005427)\nMoore, P. L., & Baden, L. R. (2022). Omicron\u2014Decoupling Infection from Severe Disease. The New England Journal of Medicine, 386(14), 1361\u20131362.\n[https://doi.org/10.1056/NEJMe2201812](https://doi.org/10.1056/NEJMe2201812)\nMurphy, W. J., & Longo, D. L. (2022). A Possible Role for Anti-idiotype Antibodies in SARS-CoV-2 Infection and Vaccination. The New England Journal of Medicine, 386(4), 394\u2013396.\n[https://doi.org/10.1056/NEJMcibr2113694](https://doi.org/10.1056/NEJMcibr2113694)\nNasiri, N., Rahmati, S., Etminan, A., Sharifi, H., Bazrafshan, A., Karamouzian, M., & Sharifi, A. (2021). Kidney Complications of COVID-19: A Systematic Review and Meta-Analysis. Journal of Research in Health Sciences, 21(1), e00503.\n[https://doi.org/10.34172/jrhs.2021.39](https://doi.org/10.34172/jrhs.2021.39)\nNazir, M., Asghar, S., Rathore, M. A., Shahzad, A., Shahid, A., Ashraf Khan, A., Malik, A., Fakhar, T., Kausar, H., & Malik, J. (2022). Menstrual abnormalities after COVID-19 vaccines: A systematic review. Vacunas (English Edition), 23, S77\u2013S87.\n[https://doi.org/10.1016/j.vacune.2022.10.019](https://doi.org/10.1016/j.vacune.2022.10.019)\nNdeupen, S., Qin, Z., Jacobsen, S., Bouteau, A., Estanbouli, H., & Igy\u00e1rt\u00f3, B. Z. (2021). The mRNA-LNP platform\u2019s lipid nanoparticle component used in preclinical vaccine studies is highly inflammatory. iScience, 24(12), 103479.\n[https://doi.org/10.1016/j.isci.2021.103479](https://doi.org/10.1016/j.isci.2021.103479)\nNtziora, F., Kostaki, E. G., Karapanou, A., Mylona, M., Tseti, I., Sipsas, N. V., Paraskevis, D., & Sfikakis, P. P. (2022). Protection of vaccination versus hybrid immunity against infection with COVID-19 Omicron variants among Health-Care Workers. Vaccine, 40(50), 7195\u20137200.\n[https://doi.org/10.1016/j.vaccine.2022.09.042](https://doi.org/10.1016/j.vaccine.2022.09.042)\nPar\u00e9s-Badell, O., Mart\u00ednez-G\u00f3mez, X., Pin\u00f3s, L., Borras-Bermejo, B., Uriona, S., Otero-Romero, S., Rodrigo-Pend\u00e1s, J. \u00c1., Cossio-Gil, Y., Agust\u00ed, A., Aguilera, C., & Campins, M. (2021). Local and Systemic Adverse Reactions to mRNA COVID-19 Vaccines Comparing Two Vaccine Types and Occurrence of Previous COVID-19 Infection. Vaccines, 9(12), 1463.\n[https://doi.org/10.3390/vaccines9121463](https://doi.org/10.3390/vaccines9121463)\nPatamatamkul, S., & Potongcamphan, M. (2023). Persistently raised blood pressure following coronavirus disease 2019 vaccines: Implication for future systematic research and monitoring. European Journal of Internal Medicine.\n[https://doi.org/10.1016/j.ejim.2023.07.006](https://doi.org/10.1016/j.ejim.2023.07.006)\nPatel, H., Sintou, A., Chowdhury, R. A., Rothery, S., Iacob, A. O., Prasad, S., Rainer, P. P., Martin\u00f3n-Torres, F., Sancho-Shimizu, V., Shimizu, C., Dummer, K., Tremoulet, A. H., Burns, J. C., Sattler, S., Levin, M., & DIAMONDS consortium. (2023). Evaluation of Autoantibody Binding to Cardiac Tissue in Multisystem Inflammatory Syndrome in Children and COVID-19 Vaccination\u2013Induced Myocarditis. JAMA Network Open, 6(5), e2314291.\n[https://doi.org/10.1001/jamanetworkopen.2023.14291](https://doi.org/10.1001/jamanetworkopen.2023.14291)\nPaul-Ehrlich-Institut. (2022, September 13). CHMP empfiehlt weitere Zulassungs\u00e4nderung von Comirnaty (BioNTech/Pfizer) als bivalenten Impfstoff mit Anpassung an die Omikron-Varianten BA.4/BA.5 f\u00fcr Auffrischimpfungen. Bundesinstitut f\u00fcr Impfstoffe und biomedizinische Arzneimittel.\n[https://www.pei.de/DE/newsroom/hp-meldungen/2022/220913-chmp-zulassungsaenderung-comirnaty-omikron-ba4-ba5-auffrischungsimpfungen.html](https://www.pei.de/DE/newsroom/hp-meldungen/2022/220913-chmp-zulassungsaenderung-comirnaty-omikron-ba4-ba5-auffrischungsimpfungen.html)\nPaul-Ehrlich-Institut. (2023a). Was wissen wir \u00fcber die Sicherheit der Lipidnanopartikel in mRNA-Impfstoffen? PEI.\n[https://www.pei.de/SharedDocs/FAQs/DE/coronavirus/sicherheit-wirksamkeit-impfstoff/9-coronavirus-impfstoff-covid-19-sicherheit-lipidnanopartikel-mrna-impfstoffe.html](https://www.pei.de/SharedDocs/FAQs/DE/coronavirus/sicherheit-wirksamkeit-impfstoff/9-coronavirus-impfstoff-covid-19-sicherheit-lipidnanopartikel-mrna-impfstoffe.html)\nPaul-Ehrlich-Institut. (2023b, Februar 1). Sicherheit von COVID-19-Impfstoffen. PEI.\n[https://www.pei.de/DE/newsroom/dossier/coronavirus/arzneimittelsicherheit.html](https://www.pei.de/DE/newsroom/dossier/coronavirus/arzneimittelsicherheit.html)\nPaul-Ehrlich-Institut. (2023c, M\u00e4rz 31). COVID-19-Impfstoffe. PEI.\n[https://www.pei.de/DE/arzneimittel/impfstoffe/covid-19/covid-19-node.html](https://www.pei.de/DE/arzneimittel/impfstoffe/covid-19/covid-19-node.html)\nPaul-Ehrlich-Institut. (2023d, September 1). Meldungen\u2014Zulassung f\u00fcr an Omikron-Variante XBB.1.5 angepassten Impfstoff Comirnaty erfolgt. Newsroom.\n[https://www.pei.de/DE/newsroom/hp-meldungen/2023/230901-zulassung-omikron-xbb-1-5-comirnaty.html?nn=170852](https://www.pei.de/DE/newsroom/hp-meldungen/2023/230901-zulassung-omikron-xbb-1-5-comirnaty.html?nn=170852)\nPaul-Ehrlich-Institut. (2023e, September 15). Meldungen\u2014Zulassung f\u00fcr an Omikron-Variante XBB.1.5 angepassten Impfstoff Spikevax erteilt. Newsroom.\n[https://www.pei.de/DE/newsroom/hp-meldungen/2023/230915-zulassung-omikron-xbb-1-5-spikevax.html](https://www.pei.de/DE/newsroom/hp-meldungen/2023/230915-zulassung-omikron-xbb-1-5-spikevax.html)\nPetrelli, F., Oldani, S., Borgonovo, K., Cabiddu, M., Dognini, G., Ghilardi, M., Parati, M. C., Petro\u2019, D., Dottorini, L., Rea, C., Lonati, V., Luciani, A., & Ghidini, A. (2023). Vitamin D3 and COVID-19 Outcomes: An Umbrella Review of Systematic Reviews and Meta-Analyses. Antioxidants, 12(2), Article 2.\n[https://doi.org/10.3390/antiox12020247](https://doi.org/10.3390/antiox12020247)\nPezzullo, A. M., Axfors, C., Contopoulos-Ioannidis, D. G., Apostolatos, A., & Ioannidis, J. P. A. (2023). Age-stratified infection fatality rate of COVID-19 in the non-elderly population. Environmental Research, 216(Pt 3), 114655.\n[https://doi.org/10.1016/j.envres.2022.114655](https://doi.org/10.1016/j.envres.2022.114655)\nPilz, S., & Ioannidis, J. P. A. (2023). Does natural and hybrid immunity obviate the need for frequent vaccine boosters against SARS-CoV-2 in the endemic phase? European Journal of Clinical Investigation, 53(2), e13906.\n[https://doi.org/10.1111/eci.13906](https://doi.org/10.1111/eci.13906)\nPilz, S., Theiler-Schwetz, V., Trummer, C., Krause, R., & Ioannidis, J. P. A. (2022). SARS-CoV-2 reinfections: Overview of efficacy and duration of natural and hybrid immunity. Environmental Research, 209, 112911.\n[https://doi.org/10.1016/j.envres.2022.112911](https://doi.org/10.1016/j.envres.2022.112911)\nPittet, L. F., Messina, N. L., Orsini, F., Moore, C. L., Abruzzo, V., Barry, S., Bonnici, R., Bonten, M., Campbell, J., Croda, J., Dalcolmo, M., Gardiner, K., Gell, G., Germano, S., Gomes-Silva, A., Goodall, C., Gwee, A., Jamieson, T., Jardim, B., \u2026 Curtis, N. (2023). Randomized Trial of BCG Vaccine to Protect against Covid-19 in Health Care Workers. New England Journal of Medicine, 388(17), 1582\u20131596.\n[https://doi.org/10.1056/NEJMoa2212616](https://doi.org/10.1056/NEJMoa2212616)\nRamakrishnan, S., Nicolau, D. V., Langford, B., Mahdi, M., Jeffers, H., Mwasuku, C., Krassowska, K., Fox, R., Binnian, I., Glover, V., Bright, S., Butler, C., Cane, J. L., Halner, A., Matthews, P. C., Donnelly, L. E., Simpson, J. L., Baker, J. R., Fadai, N. T., \u2026 Bafadhel, M. (2021). Inhaled budesonide in the treatment of early COVID-19 (STOIC): A phase 2, open-label, randomised controlled trial. The Lancet. Respiratory Medicine, 9(7), 763\u2013772.\n[https://doi.org/10.1016/S2213-2600(21)00160-0](https://doi.org/10.1016/S2213-2600(21)00160-0)\nRasmussen, M., M\u00f8ller, F. T., Gunalan, V., Baig, S., Bennedb\u00e6k, M., Christiansen, L. E., Cohen, A. S., Ellegaard, K., Fomsgaard, A., Franck, K. T., Larsen, N. B., Larsen, T. G., Lassauni\u00e8re, R., Polacek, C., Qvesel, A. G., Sieber, R. N., Rasmussen, L. D., Stegger, M., Spiess, K., \u2026 Jokelainen, P. (2023). First cases of SARS-CoV-2 BA.2.86 in Denmark, 2023. Eurosurveillance, 28(36), 2300460.\n[https://doi.org/10.2807/1560-7917.ES.2023.28.36.2300460](https://doi.org/10.2807/1560-7917.ES.2023.28.36.2300460)\nReme, B.-A., Gjesvik, J., & Magnusson, K. (2023). Predictors of the post-COVID condition following mild SARS-CoV-2 infection. Nature Communications, 14(1), Article 1.\n[https://doi.org/10.1038/s41467-023-41541-x](https://doi.org/10.1038/s41467-023-41541-x)\nReusch, J., Wagenh\u00e4user, I., Gabel, A., H\u00f6hn, A., L\u00e2m, T.-T., Krone, L. B., Frey, A., Schubert-Unkmeir, A., D\u00f6lken, L., Frantz, S., Kurzai, O., Vogel, U., Krone, M., & Petri, N. (2023). Inability to work following COVID-19 vaccination\u2013a relevant aspect for future booster vaccinations. Public Health, 222, 186\u2013195.\n[https://doi.org/10.1016/j.puhe.2023.07.008](https://doi.org/10.1016/j.puhe.2023.07.008)\nRichter, E., Liebl, D., Schulte, B., Lehmann, N., Fuhrmann, C., J\u00f6ckel, K.-H., Ioannidis, J. P. A., & Streeck, H. (2023). Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event. Scientific Reports, 13(1), Article 1.\n[https://doi.org/10.1038/s41598-023-32441-7](https://doi.org/10.1038/s41598-023-32441-7)\nRobert Koch-Institut. (2021, November 26). Epidemiologischer Steckbrief zu SARS-CoV-2 und COVID-19. Infektionskrankheiten A-Z.\n[https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief](https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief).\nRobert Koch-Institut. (2022a). W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19): 23.06.2022 \u2013 Aktualisierter Stand f\u00fcr Deutschland (Situationsbericht 23.06.2022). RKI.\n[https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-06-23.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-06-23.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2022b). W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19): 21.07.2022 \u2013 Aktualisierter Stand f\u00fcr Deutschland (Situationsbericht 21.07.2022). RKI.\n[https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-07-21.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-07-21.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2023a, Februar 9). AUFKL\u00c4RUNGSMERKBLATT Schutzimpfung (Grundimmunisierung und Auffrischimpfungen) gegen COVID-19 (Corona Virus Disease 2019). RKI.\n[https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Downloads-COVID-19/Aufklaerungsbogen-de.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Downloads-COVID-19/Aufklaerungsbogen-de.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2023b). W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19): 23.03.2023 \u2013 Aktualisierter Stand f\u00fcr Deutschland (Situationsbericht 23.03.2023). RKI.\n[https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-03-23.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-03-23.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2023c, M\u00e4rz 28). Impfung bei Kindern und Jugendlichen. RKI.\n[https://www.rki.de/SharedDocs/FAQ/COVID-Impfen/FAQ_Liste_Impfung_Kinder_Jugendliche.html](https://www.rki.de/SharedDocs/FAQ/COVID-Impfen/FAQ_Liste_Impfung_Kinder_Jugendliche.html)\nRobert Koch-Institut. (2023d, Mai 25). Epidemiologisches Bulletin 21/2023 (Nr. 21/2023). Implementierung der COVID-19-Impfung in die allgemeinen Empfehlungen der STIKO 2023.\n[https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/21_23.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/21_23.pdf?__blob=publicationFile)\nRobert Koch-Institut. (2023e). ARE-Wochenbericht des RKI 36/2023. influenza.rki.de, 36, 3.\n[https://doi.org/10.25646/11697](https://doi.org/10.25646/11697)\nRobert Koch-Institut. (2023f, September 18). Stellungnahme der STIKO anl\u00e4sslich der Zulassung von XBB.1.5-Varianten-adaptierten COVID-19-Impfstoffen f\u00fcr die Auffrischimpfung von Personen mit erh\u00f6htem Risiko f\u00fcr einen schweren Krankheitsverlauf. St\u00e4ndige Impfkommission.\n[https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Stellungnahme-COVID-19-Varianten-adaptierte-Impfstoffe.html](https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Stellungnahme-COVID-19-Varianten-adaptierte-Impfstoffe.html)\nRobert Koch-Institut. (2023g). W\u00f6chentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19): 08.06.2023 \u2013 Aktualisierter Stand f\u00fcr Deutschland (Situationsbericht 08.06.2023; Aktualisierter Stand f\u00fcr Deutschland). RKI.\n[https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-06-08.pdf?__blob=publicationFile](https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-06-08.pdf?__blob=publicationFile)\nSabaghian, T., Kharazmi, A. B., Ansari, A., Omidi, F., Kazemi, S. N., Hajikhani, B., Vaziri-Harami, R., Tajbakhsh, A., Omidi, S., Haddadi, S., Shahidi Bonjar, A. H., Nasiri, M. J., & Mirsaeidi, M. (2022). COVID-19 and Acute Kidney Injury: A Systematic Review. Frontiers in Medicine, 9, 705908.\n[https://doi.org/10.3389/fmed.2022.705908](https://doi.org/10.3389/fmed.2022.705908)\nScheibenbogen, C., Renz-Polster, H., Hohberger, B., Behrends, U., Schieffer, E., & Schieffer, B. (2023, M\u00e4rz 31). Post COVID und Post-Vakzin-Syndrom: Die Pandemie nach der Pandemie. Deutsches \u00c4rzteblatt.\n[https://www.aerzteblatt.de/archiv/230502/Post-COVID-und-Post-Vakzin-Syndrom-Die-Pandemie-nach-der-Pandemie](https://www.aerzteblatt.de/archiv/230502/Post-COVID-und-Post-Vakzin-Syndrom-Die-Pandemie-nach-der-Pandemie)\nSchroth, D., Garg, R., Bocova, X., Hansmann, J., Haass, M., Yan, A., Fernando, C., Chacko, B., Oikonomou, A., White, J., Alhussein, M. M., Giusca, S., Ochs, A., Korosoglou, G., Andr\u00e9, F., Friedrich, M. G., & Ochs, M. (2023). Predictors of persistent symptoms after mRNA SARS-CoV-2 vaccine-related myocarditis (myovacc registry). Frontiers in Cardiovascular Medicine, 10, 1204232.\n[https://doi.org/10.3389/fcvm.2023.1204232](https://doi.org/10.3389/fcvm.2023.1204232)\nSchuchmann, P., Scheuch, G., Naumann, R., Keute, M., L\u00fccke, T., Zielen, S., & Brinkmann, F. (2023). Exhaled aerosols among PCR-confirmed SARS-CoV-2-infected children. Frontiers in Pediatrics, 11.\n[https://www.frontiersin.org/articles/10.3389/fped.2023.1156366](https://www.frontiersin.org/articles/10.3389/fped.2023.1156366)\nSchumann, D. F., & Erdmann, E. (2023, Juni 15). Corona-Impfsch\u00e4den: Einer von 10.000 Geimpften will einen Impfschaden anerkennen lassen. Die Zeit.\n[https://www.zeit.de/gesundheit/2023-06/impfschaeden-corona-herzmuskelentzuendung-antrag](https://www.zeit.de/gesundheit/2023-06/impfschaeden-corona-herzmuskelentzuendung-antrag)\nSchumann, F., & W\u00fcstenhagen, C. (2023, Juni 12). Corona-Impfsch\u00e4den: \u201eUm einen Impfschaden anzuerkennen, brauchen wir drei Tatbest\u00e4nde\u201c. Die Zeit.\n[https://www.zeit.de/gesundheit/2023-06/corona-impfschaeden-hersteller-schadensersatz-myokarditis-post-vac](https://www.zeit.de/gesundheit/2023-06/corona-impfschaeden-hersteller-schadensersatz-myokarditis-post-vac)\nSchwarz, S., Jenetzky, E., Krafft, H., Maurer, T., Steuber, C., Reckert, T., Fischbach, T., & Martin, D. (2021). [Corona in Children: The Co-Ki Study]. Monatsschrift Kinderheilkunde: Organ Der Deutschen Gesellschaft Fur Kinderheilkunde, 169(1), 39\u201345.\n[https://doi.org/10.1007/s00112-020-01050-3](https://doi.org/10.1007/s00112-020-01050-3)\nSelvakumar, J., Havdal, L. B., Drevvatne, M., Brodwall, E. M., Lund Berven, L., Stiansen-Sonerud, T., Einvik, G., Leegaard, T. M., Tjade, T., Michelsen, A. E., Mollnes, T. E., Lund-Johansen, F., Holm\u00f8y, T., Zetterberg, H., Blennow, K., Sandler, C. X., Cvejic, E., Lloyd, A. R., & Wyller, V. B. B. (2023). Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults. JAMA Network Open, 6(3), e235763.\n[https://doi.org/10.1001/jamanetworkopen.2023.5763](https://doi.org/10.1001/jamanetworkopen.2023.5763)\nSemmler, A., Mundorf, A. K., Kuechler, A. S., Schulze-Bosse, K., Heidecke, H., Schulze-Forster, K., Schott, M., Uhrberg, M., Weinhold, S., Lackner, K. J., Pawlitzki, M., Meuth, S. G., Boege, F., & Ruhrl\u00e4nder, J. (2023). Chronic Fatigue and Dis-Autonomy following COVID-19 Vaccination is Distinguished from Normal Vaccination Response by Altered Blood Markers (2023090113). Preprints.\n[https://doi.org/10.20944/preprints202309.0113.v1](https://doi.org/10.20944/preprints202309.0113.v1)\nShang, W., Kang, L., Cao, G., Wang, Y., Gao, P., Liu, J., & Liu, M. (2022). Percentage of Asymptomatic Infections among SARS-CoV-2 Omicron Variant-Positive Individuals: A Systematic Review and Meta-Analysis. Vaccines, 10(7), 1049.\n[https://doi.org/10.3390/vaccines10071049](https://doi.org/10.3390/vaccines10071049)\nShoar, S., Hosseini, F., Naderan, M., & Mehta, J. L. (2020). Meta-analysis of Cardiovascular Events and Related Biomarkers Comparing Survivors Versus Non-survivors in Patients With COVID-19. The American Journal of Cardiology, 135, 50\u201361.\n[https://doi.org/10.1016/j.amjcard.2020.08.044](https://doi.org/10.1016/j.amjcard.2020.08.044)\nShrestha, N. K., Burke, P. C., Nowacki, A. S., Simon, J. F., Hagen, A., & Gordon, S. M. (2023). Effectiveness of the Coronavirus Disease 2019 (COVID-19) Bivalent Vaccine. Open Forum Infectious Diseases, ofad209.\n[https://doi.org/10.1093/ofid/ofad209](https://doi.org/10.1093/ofid/ofad209)\nSievers, C., Zacher, B., Ullrich, A., Huska, M., Fuchs, S., Buda, S., Haas, W., Diercke, M., An der Heiden, M., & Kr\u00f6ger, S. (2022). SARS-CoV-2 Omicron variants BA.1 and BA.2 both show similarly reduced disease severity of COVID-19 compared to Delta, Germany, 2021 to 2022. Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin, 27(22), 2200396.\n[https://doi.org/10.2807/1560-7917.ES.2022.27.22.2200396](https://doi.org/10.2807/1560-7917.ES.2022.27.22.2200396)\nSingh, J., Malik, P., Patel, N., Pothuru, S., Israni, A., Chakinala, R. C., Hussain, M. R., Chidharla, A., Patel, H., Patel, S. K., Rabbani, R., Patel, U., Chugh, S., & Kichloo, A. (2022). Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clinical and Experimental Medicine, 22(1), 125\u2013135.\n[https://doi.org/10.1007/s10238-021-00715-x](https://doi.org/10.1007/s10238-021-00715-x)\nSpinardi, J. R., & Srivastava, A. (2023). Hybrid Immunity to SARS-CoV-2 from Infection and Vaccination-Evidence Synthesis and Implications for New COVID-19 Vaccines. Biomedicines, 11(2), 370.\n[https://doi.org/10.3390/biomedicines11020370](https://doi.org/10.3390/biomedicines11020370)\nStein, C., Nassereldine, H., Sorensen, R. J. D., Amlag, J. O., Bisignano, C., Byrne, S., Castro, E., Coberly, K., Collins, J. K., Dalos, J., Daoud, F., Deen, A., Gakidou, E., Giles, J. R., Hulland, E. N., Huntley, B. M., Kinzel, K. E., Lozano, R., Mokdad, A. H., \u2026 Lim, S. S. (2023). Past SARS-CoV-2 infection protection against re-infection: A systematic review and meta-analysis. The Lancet, 401(10379), 833\u2013842.\n[https://doi.org/10.1016/S0140-6736(22)02465-5](https://doi.org/10.1016/S0140-6736(22)02465-5)\nStephenson, T., Shafran, R., & Ladhani, S. N. (2022). Long COVID in children and adolescents. Current Opinion in Infectious Diseases, 35(5), 461\u2013467.\n[https://doi.org/10.1097/QCO.0000000000000854](https://doi.org/10.1097/QCO.0000000000000854)\nStreeck, H., Schulte, B., K\u00fcmmerer, B. M., Richter, E., H\u00f6ller, T., Fuhrmann, C., Bartok, E., Dolscheid-Pommerich, R., Berger, M., Wessendorf, L., Eschbach-Bludau, M., Kellings, A., Schwaiger, A., Coenen, M., Hoffmann, P., Stoffel-Wagner, B., N\u00f6then, M. M., Eis-H\u00fcbinger, A. M., Exner, M., \u2026 Hartmann, G. (2020). Infection fatality rate of SARS-CoV2 in a super-spreading event in Germany. Nature Communications, 11(1), 5829.\n[https://doi.org/10.1038/s41467-020-19509-y](https://doi.org/10.1038/s41467-020-19509-y)\nTagesschau (2022, Mai 3). Viele Erwachsene in Europa sind zu dick. tagesschau.de.\n[https://www.tagesschau.de/ausland/europa/who-europa-gewicht-101.html](https://www.tagesschau.de/ausland/europa/who-europa-gewicht-101.html)\nTakefuji, Y. (2023). Impact of COVID-19 on mortality under 5 years old. Pediatric Research, 1\u20131.\n[https://doi.org/10.1038/s41390-023-02612-3](https://doi.org/10.1038/s41390-023-02612-3)\nTan, L. Y., Komarasamy, T. V., & Rmt Balasubramaniam, V. (2021). Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Frontiers in Immunology, 12, 742941.\n[https://doi.org/10.3389/fimmu.2021.742941](https://doi.org/10.3389/fimmu.2021.742941)\nTeshome, A., Adane, A., Girma, B., & Mekonnen, Z. A. (2021). The Impact of Vitamin D Level on COVID-19 Infection: Systematic Review and Meta-Analysis. Frontiers in Public Health, 9, 624559.\n[https://doi.org/10.3389/fpubh.2021.624559](https://doi.org/10.3389/fpubh.2021.624559)\nTsilingiris, D., Vallianou, N. G., Karampela, I., Liu, J., & Dalamaga, M. (2022). Potential implications of lipid nanoparticles in the pathogenesis of myocarditis associated with the use of mRNA vaccines against SARS-CoV-2. Metabolism Open, 13, 100159.\n[https://doi.org/10.1016/j.metop.2021.100159](https://doi.org/10.1016/j.metop.2021.100159)\nTuvali, O., Tshori, S., Derazne, E., Hannuna, R. R., Afek, A., Haberman, D., Sella, G., & George, J. (2022). The Incidence of Myocarditis and Pericarditis in Post COVID-19 Unvaccinated Patients\u2014A Large Population-Based Study. Journal of Clinical Medicine, 11(8), Article 8.\n[https://doi.org/10.3390/jcm11082219](https://doi.org/10.3390/jcm11082219)\nUversky, V. N., Redwan, E. M., Makis, W., & Rubio-Casillas, A. (2023). IgG4 Antibodies Induced by Repeated Vaccination May Generate Immune Tolerance to the SARS-CoV-2 Spike Protein. Vaccines, 11(5), Article 5.\n[https://doi.org/10.3390/vaccines11050991](https://doi.org/10.3390/vaccines11050991)\nU.S. Department of Health & Human Services. (2023). Electronic Support for Public Health\u2014Vaccine Adverse Event Reporting System (ESP:VAERS) | Digital Healthcare Research. Digital Healthcare Research.\n[https://digital.ahrq.gov/ahrq-funded-projects/electronic-support-public-health-vaccine-adverse-event-reporting-system](https://digital.ahrq.gov/ahrq-funded-projects/electronic-support-public-health-vaccine-adverse-event-reporting-system)\nVoleti, N., Reddy, S. P., & Ssentongo, P. (2022). Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 9, 951314.\n[https://doi.org/10.3389/fcvm.2022.951314](https://doi.org/10.3389/fcvm.2022.951314)\nWang, Q., Bowen, A., Valdez, R., Gherasim, C., Gordon, A., Liu, L., & Ho, D. D. (2023). Antibody Response to Omicron BA.4\u2013BA.5 Bivalent Booster. The New England Journal of Medicine, NEJMc2213907.\n[https://doi.org/10.1056/NEJMc2213907](https://doi.org/10.1056/NEJMc2213907)\nWang, Z., Joshi, A., Leopold, K., Jackson, S., Christensen, S., Nayfeh, T., Mohammed, K., Creo, A., Tebben, P., & Kumar, S. (2022). Association of vitamin D deficiency with COVID-19 infection severity: Systematic review and meta-analysis. Clinical Endocrinology, 96(3), 281\u2013287.\n[https://doi.org/10.1111/cen.14540](https://doi.org/10.1111/cen.14540)\nWashrawirul, C., Triwatcharikorn, J., Phannajit, J., Ullman, M., Susantitaphong, P., & Rerknimitr, P. (2022). Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: A systematic review and meta-analysis. Journal of the European Academy of Dermatology and Venereology: JEADV, 36(11), 1947\u20131968.\n[https://doi.org/10.1111/jdv.18294](https://doi.org/10.1111/jdv.18294)\nWestphal, T., Mader, M., Karsten, H., Cords, L., Knapp, M., Schulte, S., Hermanussen, L., Peine, S., Ditt, V., Grifoni, A., Addo, M. M., Huber, S., Sette, A., L\u00fctgehetmann, M., Pischke, S., Kwok, W. W., Sidney, J., & Schulze zur Wiesch, J. (2023). Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4+ T-cell response with pre-primed responses directed against common cold coronaviruses. Frontiers in Immunology, 14.\n[https://www.frontiersin.org/articles/10.3389/fimmu.2023.1182504](https://www.frontiersin.org/articles/10.3389/fimmu.2023.1182504)\nWissenschaftliches Institut der AOK. (2023, M\u00e4rz 16). Post-Covid-Erkrankungen: Wenige Betroffene, aber lange Ausfallzeiten. WIdO.\n[https://www.wido.de/news-presse/pressemitteilungen/2023/post-covid-erkrankungen/](https://www.wido.de/news-presse/pressemitteilungen/2023/post-covid-erkrankungen/)\nWorld Health Organization. (2022a). WHO Pharmaceuticals Newsletter 01/2022. WHO.\n[https://apps.who.int/iris/bitstream/handle/10665/351326/9789240042452-eng.pdf?sequence=1&isAllowed=y](https://apps.who.int/iris/bitstream/handle/10665/351326/9789240042452-eng.pdf?sequence=1&isAllowed=y)\nWorld Health Organization. (2022b). WHO Pharmaceuticals Newsletter 03/2022. WHO.\n[https://apps.who.int/iris/bitstream/handle/10665/351326/9789240042452-eng.pdf?sequence=1&isAllowed=y](https://apps.who.int/iris/bitstream/handle/10665/351326/9789240042452-eng.pdf?sequence=1&isAllowed=y)\nWorld Health Organization. (2023a, Januar 30). Statement on the fourteenth meeting of the International Health Regulations (2005) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. WHO.\n[https://www.who.int/news/item/30-01-2023-statement-on-the-fourteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic](https://www.who.int/news/item/30-01-2023-statement-on-the-fourteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic)\nWorld Health Organization. (2023b, M\u00e4rz 28). SAGE updates COVID-19 vaccination guidance. WHO.\n[https://www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance](https://www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance)\nWu, Y., Kang, L., Guo, Z., Liu, J., Liu, M., & Liang, W. (2022). Incubation Period of COVID-19 Caused by Unique SARS-CoV-2 Strains: A Systematic Review and Meta-analysis. JAMA Network Open, 5(8), e2228008.\n[https://doi.org/10.1001/jamanetworkopen.2022.28008](https://doi.org/10.1001/jamanetworkopen.2022.28008)\nYu, W., Guo, Y., Zhang, S., Kong, Y., Shen, Z., & Zhang, J. (2022). Proportion of asymptomatic infection and nonsevere disease caused by SARS-CoV-2 Omicron variant: A systematic review and analysis. Journal of Medical Virology, 94(12), 5790\u20135801.\n[https://doi.org/10.1002/jmv.28066](https://doi.org/10.1002/jmv.28066)\nXie, Y., Xu, J., Zhou, D., Guo, M., Zhang, M., Gao, Y., Liu, M., Shi, J., Yang, K., Zheng, Q., Zhao, L., Qin, Y., Hu, R., Wei, J., Zhang, J., & Tian, J. (2023). Micronutrient perspective on COVID-19: Umbrella review and reanalysis of meta-analyses. Critical Reviews in Food Science and Nutrition, 1\u201319.\n[https://doi.org/10.1080/10408398.2023.2174948](https://doi.org/10.1080/10408398.2023.2174948)\nzdfheute. (2021, November 11). Impfung gegen Corona: Noch nicht genug aufgekl\u00e4rt? zdf.de.\n[https://www.zdf.de/uri/471da2a5-a8a3-41cc-886e-571bbf7d5b0a](https://www.zdf.de/uri/471da2a5-a8a3-41cc-886e-571bbf7d5b0a)\nZhao, Y.-H., Zhao, L., Yang, X.-C., & Wang, P. (2021). Cardiovascular complications of SARS-CoV-2 infection (COVID-19): A systematic review and meta-analysis. Reviews in Cardiovascular Medicine, 22(1), 159\u2013165.\n[https://doi.org/10.31083/j.rcm.2021.01.238](https://doi.org/10.31083/j.rcm.2021.01.238)\nZuin, M., Rigatelli, G., Zuliani, G., & Roncon, L. (2021). The risk of thrombosis after acute-COVID-19 infection. QJM: Monthly Journal of the Association of Physicians, 114(9), 619\u2013620.\n[https://doi.org/10.1093/qjmed/hcab054](https://doi.org/10.1093/qjmed/hcab054)", "language": null, "image": null, "pagetype": "article", "links": ["/", "/", "https://easyverein.com/public/AeIIE2019/", "https://forum.individuelle-impfentscheidung.de", "/impfungen/covid-19.html", "/", "/aktuelles.html", "/aktuelles/covid-19-impfpflicht.html", "/aktuelles/covid-19-impfung.html", "/aktuelles/covid-19-bei-kindern-und-jugendlichen.html", "/aktuelles/covid-19-impfpflicht-verfassungsbeschwerden.html", "/masern-impfpflicht-verfassungsbeschwerden.html", "/aktuelles/masern-impfpflicht.html", "/standpunkte.html", "/standpunkte/publikationen.html", "/standpunkte/faqs.html", "/standpunkte/podcasts.html", "/standpunkte/videos.html", "/standpunkte/twitter.html", "/newsletter/standard-titel.html", "/aktionen.html", "/aktionen/lauterdnaimstoff.html", "/aktionen/ifsgehtsogarnicht.html", "/standpunkt/profisgegenimpfpflicht.html", "/impfenohnepflicht.html", "/briefaktion.html", "/aktuelles/die-corona-impfpflicht-ist-das-falsche-instrument-1.html", "/aktionen/keine-impfpflicht-fuer-beschaeftigte-im-medizinischen-und-sozialen-bereich.html", "/2ggehtgarnicht-1.html", "/aktuelles/nichtmeinaerztetag.html", "/aktuelles/deutschland-braucht-keine-impfpflicht.html", "/impfungen.html", "/impfungen/covid-19.html", "/impfungen/diphtherie.html", "/impfungen/fsme.html", "/impfungen/guertelrose.html", "/impfungen/hpv.html", "/impfungen/influenza.html", "/impfungen/masern.html", "/impfungen/meningokokken.html", "/impfungen/mumps.html", "/impfungen/polio.html", "/impfungen/roeteln.html", "/impfungen/rsv.html", "/impfungen/tetanus.html", "/impfungen/windpocken.html", "/impfempfehlungen.html", "/wer-wir-sind/arztsuche.html", "/impfempfehlungen/alternative-impfstrategien.html", "/impfempfehlungen/leitbild.html", "/impfempfehlungen/off-label-use.html", "/wer-wir-sind.html", "/wer-wir-sind/vorstand.html", "/wer-wir-sind/mitarbeiterinnen.html", "/wer-wir-sind/leitbild.html", "/wer-wir-sind/satzung.html", "/wer-wir-sind/transparenz.html", "/wer-wir-sind/gruendung.html", "/wer-wir-sind/wie-wir-arbeiten.html", "/wer-wir-sind/mitglied-werden.html", "/presse.html", "/presse/pressebilder.html", "/newsletter.html", "/newsletter/archiv.html", "/mitglied-werden.html", "/spenden.html", "https://twitter.com/individ_impfen", "https://www.linkedin.com/company/individuelle-impfentscheidung", "https://www.instagram.com/individuelle_impfentscheidung/", "https://www.youtube.com/channel/UCCppnAfYzQaf2ruYrvqH5rA/featured", "https://odysee.com/@individuelle_impfentscheidung:3", "https://open.spotify.com/show/7jgmUbf87g4Ha0whVGaIAp?si=53cbfd723be44076", "/", "/impfungen.html", "/impfungen/covid-19.html", "/glossar.html#c143", "/glossar.html#c134", "/fileadmin/Fachbeitr%C3%A4ge/COVID-19/AEFI-One_Pager-COVID-19.pdf", "/glossar.html#c45", "/glossar.html#c147", "/wer-wir-sind/wie-wir-arbeiten.html", "/standpunkte/podcasts.html", "/glossar.html#c153", "/glossar.html#c6", "/glossar.html#c123", "/glossar.html#c125", "/glossar.html#c70", "/glossar.html#c9", "/glossar.html#c23", "/glossar.html#c21", "/glossar.html#c126", "https://individuelle-impfentscheidung.de/fileadmin/Fachbeitr\u00e4ge/Omikron-Sublinien_2021_2022.png", "https://individuelle-impfentscheidung.de/fileadmin/Fachbeitr\u00e4ge/Omikron_Rekombinanten_2022_2023.png", "/glossar.html#c158", "/glossar.html#c132", "/glossar.html#c127", "/glossar.html#c129", "/glossar.html#c128", "/glossar.html#c154", "/glossar.html#c225", "/glossar.html#c8", "/glossar.html#c46", "/glossar.html#c62", "#c753", "/glossar.html#c130", "/glossar.html#c131", "/glossar.html#c155", "/glossar.html#c151", "/glossar.html#c55", "/glossar.html#c24", "/glossar.html#c18", "/glossar.html#c52", "/glossar.html#c301", "/glossar.html#c64", "/glossar.html#c102", "/glossar.html#c196", "/glossar.html#c270", "/glossar.html#c43", "/glossar.html#c88", "/glossar.html#c256", "https://cormea.org", "/glossar.html#c152", "https://covid19criticalcare.com/", "/glossar.html#c157", "/glossar.html#c233", "/glossar.html#c227", "/glossar.html#c95", "/glossar.html#c300", "/glossar.html#c94", "/glossar.html#c175", "https://individuelle-impfentscheidung.de/fileadmin/Fachbeitr\u00e4ge/COVID-19/DIVI-Intensivstation-21.Sep.2023.png", "https://individuelle-impfentscheidung.de/fileadmin/Fachbeitr\u00e4ge/COVID-19/RKI-\u00fcbermittelte-COVID-F\u00e4lle-Juni-2023.png", "/glossar.html#c146", "/glossar.html#c149", "/glossar.html#c150", "/glossar.html#c142", "/glossar.html#c140", "/glossar.html#c141", "#c751", "https://individuelle-impfentscheidung.de/fileadmin/Fachbeitr\u00e4ge/Omikron_Bazargan_et_al._2022.jpg", "/glossar.html#c107", "/glossar.html#c47", "/glossar.html#c138", "/glossar.html#c298", "/glossar.html#c230", "/glossar.html#c22", "/glossar.html#c228", "/glossar.html#c198", "/glossar.html#c26", "/glossar.html#c229", "https://individuelle-impfentscheidung.de/aktuelles/detail/stellungnahme-zur-oeffentlichen-anhoerung-des-gesundheitsausschusses.html", "/glossar.html#c135", "/glossar.html#c136", "/glossar.html#c109", "/glossar.html#c195", "/glossar.html#c100", "/glossar.html#c101", "/glossar.html#c57", "/glossar.html#c51", "/glossar.html#c60", "/glossar.html#c148", "/glossar.html#c299", "/glossar.html#c14", "/glossar.html#c174", "/glossar.html#c86", "https://www.ukgm.de/ugm_2/deu/umr_kar/51186.html", "https://www.charite.de/klinikum/themen_klinikum/themenschwerpunkt_coronavirus/post_covid_19_behandlungen_an_der_charite/", "https://cormea.org/", "/glossar.html#c137", "/glossar.html#c28", "/glossar.html#c260", "/glossar.html#c296", "/glossar.html#c297", "/glossar.html#c232", "/glossar.html#c66", "https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/PM_2023-04-25.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/aefi-fordert-stiko-muss-impfempfehlungen-der-realitaet-anpassen.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/aefi-fordert-stiko-muss-impfempfehlungen-der-realitaet-anpassen.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/aefi-positionspapier-fuer-ein-umdenken-in-der-impfpolitik.html", "/glossar.html#c237", "/glossar.html#c145", "https://individuelle-impfentscheidung.de/aktionen/keine-impfpflicht-fuer-beschaeftigte-im-medizinischen-und-sozialen-bereich.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/kurz-infos-zum-buch-die-corona-impfpflicht-ist-das-falsche-instrument", "https://individuelle-impfentscheidung.de/aktuelles/detail/ein-buch-gegen-das-vergessen.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/stellungnahme-zur-oeffentlichen-anhoerung-des-gesundheitsausschusses.html", "https://individuelle-impfentscheidung.de/aktuelles/detail/stellungnahme-an-das-bundesverfassungsgericht-zur-einrichtungsbezogenen-corona-impfpflicht.html", "https://individuelle-impfentscheidung.de/aktuelles/die-einrichtungsbezogene-corona-impfpflicht-ist-verfassungswidrig.html", "/fileadmin/Downloads/%C3%84FI-Positionspapier_F%C3%BCr-ein-Umdenken-in-der-Impfpolitik.pdf", "https://impfen-mit-sinn-und-verstand.podigee.io/23-22-fur-ein-umdenken-in-der-impfpolitik", "#", "#", "https://doi.org/10.1001/jama.2023.16498", "https://doi.org/10.1177/17539447221105013", "https://doi.org/10.1007/s15010-021-01666-x", "https://doi.org/10.15167/2421-4248/jpmh2021.62.2.1627", "https://doi.org/10.1016/j.cmi.2022.03.021", "https://doi.org/10.1016/S0140-6736(22)00941-2", "https://doi.org/10.1056/NEJMc2303753", "https://doi.org/10.3390/nu14163252", "https://doi.org/10.1002/jgm.3435", "https://doi.org/10.1016/j.isci.2023.106733", "https://doi.org/10.1016/S1473-3099(22)00801-5", "https://www.welt.de/politik/deutschland/plus241005455/Corona-Impfung-US-Gesundheitsbehoerde-liess-sich-von-acht-Labormaeusen-ueberzeugen.html", "https://www.welt.de/politik/deutschland/plus239736199/Corona-Impfung-2-5-Millionen-Patienten-meldeten-Nebenwirkungen-in-Deutschland.html", "https://doi.org/10.3390/vaccines11091431", "https://doi.org/10.1038/s41591-022-02051-3", "https://doi.org/10.1101/2023.04.16.23288205", "https://impfdashboard.de/", "https://www.infektionsschutz.de/coronavirus/basisinformationen/symptome-und-krankheitsverlauf/", "https://doi.org/10.1038/d41586-022-02806-5", "https://doi.org/10.5414/CN110357", "https://doi.org/10.1093/infdis/jiac136", "https://doi.org/10.1136/postgradmedj-2020-139388", "https://www.cormea.de", "https://doi.org/10.1093/eurheartj/ehad339", "https://cen.acs.org/pharmaceuticals/drug-delivery/Without-lipid-shells-mRNA-vaccines/99/i8", "https://doi.org/10.3201/eid2806.220158", "https://register.awmf.org/de/leitlinien/detail/053-054", "https://dgpi.de/awi-erfassung-update/", "https://www.intensivregister.de/#/aktuelle-lage/zeitreihen", "https://www.aerzteblatt.de/nachrichten/140205/Immune-Imprinting-Kann-Impfen-Suende-sein", "https://www.pharmazeutische-zeitung.de/angepasste-covid-19-impfstoffe-wirksam-gegen-eg5-141829/", "https://doi.org/10.1111/bcp.15799", "https://www.aerzteblatt.de/archiv/230476/Long-COVID-und-die-Psycho-Ecke-Wiedergeburt-eines-reduktionistischen-Krankheitsverstaendnisses", "https://germany.representation.ec.europa.eu/news/eu-kommission-lasst-angepasste-impfstoffe-von-biontech-und-moderna-zu-2022-09-02_de", "https://doi.org/10.1093/ije/dyab145", "https://doi.org/10.25646/7037", "https://doi.org/10.1038/s41562-023-01654-1", "https://www.focus.de/gesundheit/coronaimpfung-impfstoff-rna-in-muttermilch-nachgewiesen-was-das-nun-fuer-muetter-bedeutet_id_154659625.html", "https://www.focus.de/gesundheit/coronavirus/seltene-schwere-nebenwirkungen-253-faelle-in-deutschland-die-6-wichtigsten-fragen-zu-impfschaeden_id_184560185.html", "https://doi.org/10.1002/14651858.CD015775", "https://doi.org/10.1101/2022.10.10.22280915", "https://doi.org/10.3390/vaccines11050996", "https://doi.org/10.1111/eci.13559", "https://doi.org/10.1016/j.amepre.2022.09.002", "https://www.aerzteblatt.de/archiv/225071/Post-Vac-Syndrom-Seltene-Folgen-nach-Impfung", "https://doi.org/10.1016/j.oftale.2023.05.009", "https://doi.org/10.1016/j.ajpath.2020.08.009", "https://doi.org/10.3390/pathogens11020269", "https://doi.org/10.1001/jamapediatrics.2022.3581", "https://doi.org/10.1016/j.ebiom.2023.104800", "https://doi.org/10.1007/s11302-021-09814-6", "https://doi.org/10.2165/00002018-200629050-00003", "https://www.hartgroup.org/measuring-the-extent-of-the-myocarditis-iceberg/", "https://doi.org/10.1136/archdischild-2022-324455", "https://doi.org/10.1056/NEJMc2306683", "https://doi.org/10.1136/bmjmed-2022-000373", "https://www.healthdata.org/covid/covid-19-vaccine-efficacy-summary", "http://104630.", "https://doi.org/10.1126/science.abi5273", "https://doi.org/10.2478/sjph-2022-0017", "https://doi.org/10.1001/jamacardio.2022.0583", "https://doi.org/10.7759/cureus.39816", "https://doi.org/10.1038/s41591-023-02228-4", "https://doi.org/10.1002/jmv.28522", "https://doi.org/10.3390/biology10080752", "https://doi.org/10.7759/cureus.44684", "https://doi.org/10.1038/s41591-022-02162-x", "https://doi.org/10.1101/2023.01.22.525079", "https://doi.org/10.1038/s41467-023-37051-5", "https://doi.org/10.3389/fphar.2023.1144824", "https://doi.org/10.20452/pamw.16402", "https://doi.org/10.1038/s41598-021-95565-8", "https://doi.org/10.1038/s41467-022-33328-3", "https://doi.org/10.1001/jamanetworkopen.2021.37257", "https://doi.org/10.1136/bmj.p2097", "https://doi.org/10.1001/jamanetworkopen.2022.9317", "https://doi.org/10.1016/S0140-6736(22)00109-X", "https://doi.org/10.1038/s41598-023-32636-y", "https://doi.org/10.1056/NEJMc2209479", "https://doi.org/10.3390/tropicalmed7080196", "https://doi.org/10.1055/a-1913-4377", "https://www.berliner-zeitung.de/wirtschaft-verantwortung/corona-pandemie-gastbeitrag-biontech-impfstoff-kein-polydispersitaetstest-vom-paul-ehrlich-institut-li.321577", "https://www.mdr.de/wissen/faktencheck/faktencheck-impfung-muttermilch-100.html", "https://doi.org/10.1016/j.lanepe.2022.100453", "https://doi.org/10.1186/s40001-022-00648-5", "https://10.0.3.233/jamanetworkopen.2023.10650", "https://doi.org/10.1136/bmjgh-2021-005427", "https://doi.org/10.1056/NEJMe2201812", "https://doi.org/10.1056/NEJMcibr2113694", "https://doi.org/10.34172/jrhs.2021.39", "https://doi.org/10.1016/j.vacune.2022.10.019", "https://doi.org/10.1016/j.isci.2021.103479", "https://doi.org/10.1016/j.vaccine.2022.09.042", "https://doi.org/10.3390/vaccines9121463", "https://doi.org/10.1016/j.ejim.2023.07.006", "https://doi.org/10.1001/jamanetworkopen.2023.14291", "https://www.pei.de/DE/newsroom/hp-meldungen/2022/220913-chmp-zulassungsaenderung-comirnaty-omikron-ba4-ba5-auffrischungsimpfungen.html", "https://www.pei.de/SharedDocs/FAQs/DE/coronavirus/sicherheit-wirksamkeit-impfstoff/9-coronavirus-impfstoff-covid-19-sicherheit-lipidnanopartikel-mrna-impfstoffe.html", "https://www.pei.de/DE/newsroom/dossier/coronavirus/arzneimittelsicherheit.html", "https://www.pei.de/DE/arzneimittel/impfstoffe/covid-19/covid-19-node.html", "https://www.pei.de/DE/newsroom/hp-meldungen/2023/230901-zulassung-omikron-xbb-1-5-comirnaty.html?nn=170852", "https://www.pei.de/DE/newsroom/hp-meldungen/2023/230915-zulassung-omikron-xbb-1-5-spikevax.html", "https://doi.org/10.3390/antiox12020247", "https://doi.org/10.1016/j.envres.2022.114655", "https://doi.org/10.1111/eci.13906", "https://doi.org/10.1016/j.envres.2022.112911", "https://doi.org/10.1056/NEJMoa2212616", "https://doi.org/10.1016/S2213-2600(21)00160-0", "https://doi.org/10.2807/1560-7917.ES.2023.28.36.2300460", "https://doi.org/10.1038/s41467-023-41541-x", "https://doi.org/10.1016/j.puhe.2023.07.008", "https://doi.org/10.1038/s41598-023-32441-7", "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Steckbrief", "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-06-23.pdf?__blob=publicationFile", "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2022-07-21.pdf?__blob=publicationFile", "https://www.rki.de/DE/Content/Infekt/Impfen/Materialien/Downloads-COVID-19/Aufklaerungsbogen-de.pdf?__blob=publicationFile", "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-03-23.pdf?__blob=publicationFile", "https://www.rki.de/SharedDocs/FAQ/COVID-Impfen/FAQ_Liste_Impfung_Kinder_Jugendliche.html", "https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2023/Ausgaben/21_23.pdf?__blob=publicationFile", "https://doi.org/10.25646/11697", "https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Stellungnahme-COVID-19-Varianten-adaptierte-Impfstoffe.html", "https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenbericht_2023-06-08.pdf?__blob=publicationFile", "https://doi.org/10.3389/fmed.2022.705908", "https://www.aerzteblatt.de/archiv/230502/Post-COVID-und-Post-Vakzin-Syndrom-Die-Pandemie-nach-der-Pandemie", "https://doi.org/10.3389/fcvm.2023.1204232", "https://www.frontiersin.org/articles/10.3389/fped.2023.1156366", "https://www.zeit.de/gesundheit/2023-06/impfschaeden-corona-herzmuskelentzuendung-antrag", "https://www.zeit.de/gesundheit/2023-06/corona-impfschaeden-hersteller-schadensersatz-myokarditis-post-vac", "https://doi.org/10.1007/s00112-020-01050-3", "https://doi.org/10.1001/jamanetworkopen.2023.5763", "https://doi.org/10.20944/preprints202309.0113.v1", "https://doi.org/10.3390/vaccines10071049", "https://doi.org/10.1016/j.amjcard.2020.08.044", "https://doi.org/10.1093/ofid/ofad209", "https://doi.org/10.2807/1560-7917.ES.2022.27.22.2200396", "https://doi.org/10.1007/s10238-021-00715-x", "https://doi.org/10.3390/biomedicines11020370", "https://doi.org/10.1016/S0140-6736(22)02465-5", "https://doi.org/10.1097/QCO.0000000000000854", "https://doi.org/10.1038/s41467-020-19509-y", "https://www.tagesschau.de/ausland/europa/who-europa-gewicht-101.html", "https://doi.org/10.1038/s41390-023-02612-3", "https://doi.org/10.3389/fimmu.2021.742941", "https://doi.org/10.3389/fpubh.2021.624559", "https://doi.org/10.1016/j.metop.2021.100159", "https://doi.org/10.3390/jcm11082219", "https://doi.org/10.3390/vaccines11050991", "https://digital.ahrq.gov/ahrq-funded-projects/electronic-support-public-health-vaccine-adverse-event-reporting-system", "https://doi.org/10.3389/fcvm.2022.951314", "https://doi.org/10.1056/NEJMc2213907", "https://doi.org/10.1111/cen.14540", "https://doi.org/10.1111/jdv.18294", "https://www.frontiersin.org/articles/10.3389/fimmu.2023.1182504", "https://www.wido.de/news-presse/pressemitteilungen/2023/post-covid-erkrankungen/", "https://apps.who.int/iris/bitstream/handle/10665/351326/9789240042452-eng.pdf?sequence=1&isAllowed=y", "https://apps.who.int/iris/bitstream/handle/10665/351326/9789240042452-eng.pdf?sequence=1&isAllowed=y", "https://www.who.int/news/item/30-01-2023-statement-on-the-fourteenth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-coronavirus-disease-(covid-19)-pandemic", "https://www.who.int/news/item/28-03-2023-sage-updates-covid-19-vaccination-guidance", "https://doi.org/10.1001/jamanetworkopen.2022.28008", "https://doi.org/10.1002/jmv.28066", "https://doi.org/10.1080/10408398.2023.2174948", "https://www.zdf.de/uri/471da2a5-a8a3-41cc-886e-571bbf7d5b0a", "https://doi.org/10.31083/j.rcm.2021.01.238", "https://doi.org/10.1093/qjmed/hcab054", "/", "/aktuelles.html", "/standpunkte.html", "/aktionen.html", "/impfungen.html", "/impfempfehlungen.html", "/wer-wir-sind.html", "/presse.html", "/newsletter.html", "/mitglied-werden.html", "/spenden.html", "/standpunkte.html", "/standpunkte/publikationen.html", "/standpunkte/faqs.html", "/standpunkte/podcasts.html", "/standpunkte/videos.html", "/standpunkte/twitter.html", "/newsletter/standard-titel.html", "/impfungen.html", "/impfungen/covid-19.html", "/impfungen/diphtherie.html", "/impfungen/fsme.html", "/impfungen/guertelrose.html", "/impfungen/hpv.html", "/impfungen/influenza.html", "/impfungen/masern.html", "/impfungen/meningokokken.html", "/impfungen/mumps.html", "/impfungen/polio.html", "/impfungen/roeteln.html", "/impfungen/rsv.html", "/impfungen/tetanus.html", "/impfungen/windpocken.html", "/wer-wir-sind.html", "/wer-wir-sind/vorstand.html", "/wer-wir-sind/mitarbeiterinnen.html", "/wer-wir-sind/leitbild.html", "/wer-wir-sind/satzung.html", "/wer-wir-sind/transparenz.html", "/wer-wir-sind/gruendung.html", "/wer-wir-sind/wie-wir-arbeiten.html", "/datenschutz.html", "/impressum.html", "", "https://twitter.com/individ_impfen", "https://www.linkedin.com/company/individuelle-impfentscheidung", "https://www.instagram.com/individuelle_impfentscheidung/", "https://www.youtube.com/channel/UCCppnAfYzQaf2ruYrvqH5rA/featured", "https://odysee.com/@individuelle_impfentscheidung:3", "https://open.spotify.com/show/7jgmUbf87g4Ha0whVGaIAp?si=53cbfd723be44076", "/datenschutz.html", null, "/datenschutz.html", null, null, null, "https://forum.individuelle-impfentscheidung.de", "/impfungen/covid-19.html", "https://easyverein.com/public/AeIIE2019/applicationform/", "/impfungen/covid-19.html", "https://easyverein.com/public/AeIIE2019", "/impfungen/covid-19.html", "https://easyverein.com/public/AeIIE2019/applicationform/", "/impfungen/covid-19.html"]}